Related references
Note: Only part of the references are listed.Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
Tyler N. Starr et al.
SCIENCE (2021)
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
Yue Zheng et al.
VIROLOGY JOURNAL (2021)
Anomalous collapses of Nares Strait ice arches leads to enhanced export of Arctic sea ice
G. W. K. Moore et al.
NATURE COMMUNICATIONS (2021)
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Piyada Supasa et al.
CELL (2021)
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
Emma C. Thomson et al.
CELL (2021)
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Wilfredo F. Garcia-Beltran et al.
CELL (2021)
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
Xiaoying Shen et al.
CELL HOST & MICROBE (2021)
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
Allison J. Greaney et al.
CELL HOST & MICROBE (2021)
Genomic Characterization of a Novel SARS-CoV-2 Lineage from Rio de Janeiro, Brazil
Carolina M. Voloch et al.
JOURNAL OF VIROLOGY (2021)
Detection of a SARS-CoV-2 variant of concern in South Africa
Houriiyah Tegally et al.
NATURE (2021)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang et al.
NATURE (2021)
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Zijun Wang et al.
NATURE (2021)
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Xuping Xie et al.
NATURE MEDICINE (2021)
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera
Alexander Muik et al.
SCIENCE (2021)
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
Adam K. Wheatley et al.
NATURE COMMUNICATIONS (2021)
The effect of spike mutations on SARS-CoV-2 neutralization
Chloe Rees-Spear et al.
CELL REPORTS (2021)
Transmission dynamics and evolutionary history of 2019-nCoV
Xingguang Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
An interactive web-based dashboard to track COVID-19 in real time
Ensheng Dong et al.
LANCET INFECTIOUS DISEASES (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
U1 snRNP regulates cancer cell migration and invasion in vitro
Jung-Min Oh et al.
NATURE COMMUNICATIONS (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
Xiaolong Tian et al.
EMERGING MICROBES & INFECTIONS (2020)
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
Katharine H. D. Crawford et al.
VIRUSES-BASEL (2020)
Isolation and rapid sharing of the 2019 novel coronavirus (SAR-CoV-2) from the first patient diagnosed with COVID-19 in Australia
Leon Caly et al.
MEDICAL JOURNAL OF AUSTRALIA (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
Tyler N. Starr et al.
CELL (2020)
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Qianqian Li et al.
CELL (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli et al.
CELL (2020)
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
Jingyun Yang et al.
NATURE (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan et al.
NATURE (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu et al.
NATURE (2020)
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction
Chee Wah Tan et al.
NATURE BIOTECHNOLOGY (2020)
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
Jennifer A. Juno et al.
NATURE MEDICINE (2020)
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum et al.
SCIENCE (2020)
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer et al.
SCIENCE (2020)
Emergence of genomic diversity and recurrent mutations in SARS-CoV-2
Lucy van Dorp et al.
INFECTION GENETICS AND EVOLUTION (2020)
A simple protein-based surrogate neutralization assay for SARS-CoV-2
Kento T. Abe et al.
JCI INSIGHT (2020)
HSP70-eIF4G Interaction Promotes Protein Synthesis and Cell Proliferation in Hepatocellular Carcinoma (vol 12, 2262, 2020)
Meng Wang et al.
CANCERS (2020)
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
David S. Khoury et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum et al.
ELIFE (2020)
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients
Nisreen M. A. Okba et al.
EMERGING INFECTIOUS DISEASES (2020)
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
Hongyi Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
Jianhui Nie et al.
EMERGING MICROBES & INFECTIONS (2020)
Mapping the Evolutionary Potential of RNA Viruses
Patrick T. Dolan et al.
CELL HOST & MICROBE (2018)
Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus
Ben Hu et al.
PLOS PATHOGENS (2017)
xMAP Technology: Applications in Detection of Pathogens
Nikol Reslova et al.
FRONTIERS IN MICROBIOLOGY (2017)
Data, disease and diplomacy: GISAID's innovative contribution to global health
Stefan Elbe et al.
GLOBAL CHALLENGES (2017)
Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2
WH Li et al.
EMBO JOURNAL (2005)
Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice
K Subbarao et al.
JOURNAL OF VIROLOGY (2004)
Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2
WH Li et al.
JOURNAL OF VIROLOGY (2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
Share Paper
